Dc. Chung et al., ANALYSIS OF THE RETINOBLASTOMA TUMOR-SUPPRESSOR GENE IN PANCREATIC ENDOCRINE TUMORS, Clinical endocrinology, 47(5), 1997, pp. 523-528
OBJECTIVES The molecular pathogenesis of human pancreatic endocrine tu
mours (PETs) is largely unknown. One attractive candidate gene for inv
olvement in pancreatic endocrine neoplasia is the retinoblastoma (Rb)
tumour suppressor gene, A deletion of the Rb gene was recently describ
ed in a human insulinoma, In addition, mice harbouring a null mutation
in the Rb gene bred with p53 mutant mice develop pancreatic endocrine
tumours, Therefore, we sought to determine the role that allelic loss
of Rb may play in a large series of human pancreatic endocrine tumour
s. PATIENTS AND MEASUREMENTS 46 pancreatic endocrine tumours were obta
ined from 41 patients, Utilizing genomic DNA isolated from the tumour
samples and control normal cells, 2 highly polymorphic microsatellite
loci (D13S153 and Rb 1.20) located within the Rb gene were PCR amplifi
ed and examined for loss of heterozygosity, RESULTS 2 patients were ho
mozygous at both loci and thus uninformative, The remaining 39 had inf
ormative markers at one or both of these loci, and none of the tumours
from these patients demonstrated allelic loss of Rb. CONCLUSIONS In t
umours in which Rb inactivation is pathogenetically important, somatic
loss of one Rb allele commonly accompanies a point mutation or microd
eletion within the other allele, Thus, the absence of demonstrable all
elic loss in this large series strongly suggests that Rb gene inactiva
tion is not frequently involved in the pathogenesis of human pancreati
c endocrine tumours.